Solutrol® Technology

These images are fictionalized for illustrative purposes only.

Solutrol Extended-Release Technology

Solutrol is proprietary extended-release technology that uses a unique matrix to deliver Oxtellar XR evenly and at a controlled rate over a 24-hour period.1,2

Click on the video below for more information on how Solutrol technology works.

Solutrol Technology Video

References

  1. Data on file. Supernus Pharmaceuticals, Inc. Rockville, MD.
  2. French JA, Baroldi P, Brittain ST, Johnson JK; on behalf of PROSPER Investigators Study Group. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial. Acta Neurol Scand. 2014;129:143-153.